MODERN VIEWS ON GEPATOPROTECTORS (ACCORDING TO META-ANALYSIS)
DOI:
https://doi.org/10.54890/.v4i4.593Abstract
Abstract: Objectives: Critical analysis of the efficacy and safety of "hepatoprotectors" in terms of evidence-based medicine. Materials and methods: journals, meta-analyzes of RCT, Cochrane Database of syst. rev. Results: What a perfect hepatoprotectors so far does not exist. Prove to have different degrees of efficacy of UDCA, EFL, amino acid preparations. Silymarin preparations should be considered as gepatoprotectors with suspected, but unproven efficacy, which can be used under certain conditions.
Keywords:
gepatoprotectors, evidence-based medicine, drugs, efficacy, safety, a meta-analysis of RCT.References
1. Fan, J.G. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010 [Text] / Fan J.G., Jia J.D., Li Y.M. et al. // J. Dig. Dis. – 2011. – Vol. 12, N 1. – P. 38–44.
2. Kumagi, T. Primary biliary cirrhosis [Text] / Kumagi, T., Heathcote E.J. // Orphanet J. Rare Dis. – 2008. – Vol. 3. – P. 1–17.
3. Rambaldi, A. Milk thistle for alcoholic and/or hepatitis B or C liver diseases – a systematic Cochrane hepato-biliary group review with meta-analyses of randomized clinical trials [Text] / Rambaldi, A., Bradly, P.J., Iaquinto, G. [et al.] // Am. J. Gastroenterol. – 2005. – Vol. 100, N 11. – P. 2583-2591.
4. Ferenci, P. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver [Text] / Ferenci, P., Dragosics B., Dittrich, H. [et al.] // J. Hepatol. – 1989. – Vol. 9, N 1. – P. 105-113.
5. Trinchet, J.C. Treatment of alcoholic hepatitis with silymarin. A double blind comparative study in 116 patients [Text] / Trinchet, J.C., Coste, T., Levy, V.G. [et al.] // Gastroenterol. Clin. Biol. – 1989. – Vol. 13, N 4. – P. 120-124.
6. Vogel, G. цит. по Юрьев, К.Л. Силимарин: эффекты и механизмы действия, клиническая эффективность и безопасность.Часть II. Обзор доказательств клинической эффективности и безопасность [Текст] / К.Л. Юрьев // Украинский медицинский журнал. – 2010. - № 3 (77). – С. 59- 66.
7. Fructus Silybi Mariae. [Text] / World Health Organization, Geneva // WHO monographs on selected medicinal plants. - 2002. – Vol. 2. - Р. 300-316. (http://apps.who.int/medicinedocs/en/d/Js4927e/29.html).
8. Floersheim, G.L. Clinical death-cap (Amanita phal-loides) poisoning: prognostic factors and therapeutic measures. Analysis of 205 cases. [Text] / Floersheim, G.L. Weber, O., Tschumi, P., Ulbrich, M. // Schweiz. Med. Wochenschr. - 1982. - Vol. 112, № 34. – Р. 1164-1177.
9. Hruby, K. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. . [Text] / Hruby, K., Csomos, G., Fuhrmann, M., Thaler, H. // Hum. Toxicol. – 1983а. - Vol. 2, № 2. – Р. 183–195.
10. Hruby, K. Pharmacotherapy of Amanita phalloides poisoning using silybin. [Text] / Hruby, K., Fuhrmann, M., Csomos, G., Thaler, H. // Wien. Klin. Wochenschr. - 1983b. - Vol. 95, №7. – Р. 225-231.
11. Hashemi, S.J., A placebocontrolled trial of silymarin in patients with nonalcoholic fatty liver disease [Text] / Hashemi, S.J., Hajiani, E., Sardabi, E.H. // Hepat.Mon. – 2009. – Vol. 9, N 4. – P. 265-270.
12. Матвеев, А.В. Гепатопротективные свойства силимарина [Текст] / А.В. Матвеев, Е.И. Коняева, В.П. Курченко, А.С. Щекатихина // Эксп.клин. гастроэнтерол. – 2011. - №2. – С. 130-136.
13. Щекатихина, А.С. Гепатопротекторные свойства флаволигнанов [Текст] / А.С. Щекатихина // Труды Белорусского гос.ун-та. – 2009.–T. 4, №1. – С. 27-48.
14. Miglio, F. Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, random-ized, parallel-group, placebo-controlled prospective clinical study [Text] / Miglio, F., Rovati, L.C., Santoro, А. // Arzneimittelforschung. - 2000. - Vol. 50, №8. – Р. 722-727.
15. Abdelmalek, M.F. Betaine for nonalcoholic fatty liver dis-ease: Results of a randomized placebocontrolled trial [Text] / Abdelmalek, M.F., Sanderson, S.O., Angulo, P., Soldevila-Pico, C., Liu, C., Peter, J., Lindor, K.D. // Hepatology. - 2009. - Vol. 50, №6. – Р. 1818-1826.
16. MAX BAYARD. East Tennessee State University, Quillen College of Medicine, Johnson City, Tennessee [Text] / MAX BAYARD, JIM HOLT, EILEEN BOROUGHS // Am Fam Physician. – 2006. - Vol. 73. №11. Р. 1961-1968.
17. Plevris J.N., Ursodeoxycholic acid in the treatment of alcoholic liver disease [Text] / Plevris J.N. // Eur J Gastroenterol Hepatol. - 1991. - Vol. 3. - Р. 653-656.
18. Pelletier, G. A randomized controlled trial of ursodeoxycholic acid in patients with alcoholinduced cirrhosis and jaundice [Text] / Pelletier, G., Roulot, D. [et al,] and the URSOMAF Group // Hepatology. – 2003. - №37. – P. 887-892.
Downloads
Published
How to Cite
Issue
Section
